MISSION

To contribute to the market of health products and services that surpass the expectations of our clients in the matter of quality and availability, all of it based on strengthening the development of the therapeutic areas of obesity, gastroenterology, central nervous system and metabolics, complemented with other areas or niches of market that constitute a very attractive opportunity for the company.

VISION

To achieve sales of 100 million Dollars by the year 2012, always looking for sustained growth and proper retribution for the workers and shareholders in the company.

VALUES

EFFECTIVENESS Working well with commitment and with proper opportunity .

QUALITY Surpass the expectations of our clients in terms or quality of products and services to

customers.

CREATIVITY Improving permanently our processes and our portfolio of products and services.

LOYALTY To develop and sustain a sense of affiliation and identity with the Medix® group

PASSION Perform activities with perseverance end enthusiasm .

COMMITMENT To assume responsibilities and comply them fully.

INTEGRATION To achieve our objectives and to increase our productivity through team work.

PROCESS OPERATION

Companies growth based on proper and adequate integration and efficiency of all processes .

medix has been evolving with strong social commitment, and providing o u r h u m a n , f i n a n c i a l a n d technological assets/resources towards continuous improvement of ourselves and our environment. W i t h o v e r m o r e t h a n 4 7 5 collaborators, medix has been involved in the quest of new horizons that will allow us to provide broader, better service to our customers in all areas.

medix has over 50 years o f exper ience in the Mexican market ; th is experience gives medix a highly competitive edge in national and international markets.

Our competitive edge is d u e t o t h e q u a l i t y , efficiency and safety we o f f e r t o h e a l t h c a r e p r a c t i t i o n e r s a n d consumers.

Medix Group

GRUPO MEDIX CHART 2007

GRUPO MEDIX

Real State Companies

Printing Company.

Financial and loan

Companies

Productos Medix S.A.

de C.V.

Short Term Hospital Center

New center for

development and

research.

Leasing Companies

Organizational Health Division medix Chart Group

Chairrman of the Board Grupo Medix

Julio Hoth y Alatriste

CEO Health Companies Carlos Lopez Patan

Corporate Services Grupo Medix Audiit Ernesto Valllet Haces

Legal Director Mario Lazcano Torres

Operations Director Enrique Reyna

Technical Director Carmen Orta

CFO Jorge Santiago

Assitance Services Renato Novoa

New Products and planeation.

Roberto Goti

Commercial Director

Carlos Bujosevich

Corporate Services Victor ESPINOZA

OFFICIAL AUTHORIZATIONS

Pharmaceutical Industry Database

2. Sanitary License No. 09 004 02 0032 3. Federal Environmental License (LAU). (ren.10/Jun.2004)

4. Environmental License Mexico City

5. Certificate of Good Production Practices for raw material and dental products 6. Certification of Good Manufacturing Practices

7. Authorized Production Lines.

7.1 Hormone Production. Solid oral presentations: Capsules, pills, tablets

7.2 Production of Herbal Products. Solid, liquid and semisolid oral presentations

7.3 Goods and services. Dietary Supplements. Separate areas: Cleaning, Perfume and Beauty, Warehouse for raw material

7.4 Dental Product production.

7.5 Healing/First-Aid products.

8. Authorized Allopathic Pharmaceuticals

8.1 Oral Solids: Capsules, pills, tablets

8.2 Oral Liquids: Solutions, emulsions, syrups

8.3 Semisolids: Suppositories: creams, gels, ovules, ointments

9.- Invima Certified Plant .

10.- Conacyt Award Achievement.

Product Engineering actualizar por planta.

Critical Systems Projects

CRITICAL SYSTEM

COMPRESSED AIR Basic and Conceptual Engineering Detail Engineering Adquisition of Equipment AIR CONDITIONING (HVAC) Basic and Conceptual Engineering

PURIFIED WATER Basic and Conceptual Engineering

Preventative Maintenance Program

PLANT ENGINEERING

MAINTENANCE PROGRAM COMPLY WITH PREVENTIVE MAINTENANCE Mechanical Civil HOURS OF MACHINERY NON-USE Production Machinery in non-use for correctional practices

Preventative Maintenance

Outsourcing Services for Third Parties.

» Lemery Laboratories » Serral Laboratories »  Innovare Laboratory » New Beginnings » Helm of Mexico » Combe Lab. » Hispanoamericana Lab. » Servicio Empresarial Total » Micrometrix Lab. » Solvay

MONTHLY UNITS CAPACITY

USED DESCRIPTION

.

LINER 170,000 44.5% BLOWER 99,000 60.2% INJECTOR 138,600 58.2% BAND TABLE 82,500 49.2% IMA BLISTERPACKAGING 206,250 48.4% NATURAL FIT 19,800 50.2% LIQUIDS 24,750 0.0% CARTON PACKAGING 277,200 49.5% ALTERNATIVE PACKAGING 14,850 50.5% GRANULATES 7,600 78.9% PILLS 775,500 32.4% MICROSPHERES 1,683 53.8% DUMOULIN BLENDER 1,980 34.1% TABLETS 36,630,000 81.4% ENCAPSULATES 4,125,000 84.5% CREAMS 56,000 73.1% HORMONALS 198,000 41.9% DISPENSARY 25 92.9% CAPSULES II 1,650,000 82.0% MIXER 7,000 82.9%

Levels of Production and installation capacity

Production Plant Production Plant

Outside VIEW

Microbiology Department

Quality Control and Quality Assurance Department

GLATT. Granulate Blender

T.K. FIELDER. Dry Granulate Machine

Sugar and Filmcoating Blenders

Blender Mix

V- Blender Mix

Liquid & Emulsion Reactor

Filmcoating & Microspheres Procedure Machine

KILLIAN T200. Compressed Tablet Machine

SYNTHESIS 300. Compressed Tablet Machine

MG2. Capsule Fillingmachine

Semiautomatic Capsule Fillingmachine

IMA. Blisterpack Machine

Tube Fillingmachine (For creams)

Liquid Fillingmachine

Manual Packaging Area of finished Product

V2. Packaging Machine

INSIDE VIEW

Pharmaceutical Forms Pharmaceutical Forms

medix Capsules

Logistics Management. Warehouse

Makes the Diference

Slow and sustained therapeutical effect that allows for rapid recovery.

Avoids the ups and downs in active concentrations common in conventional fast-absorbing drugs.

Avoids fluctuation in the pharmacological response - allows for easy dose-adjustments.

The bioavailability of drugs used with the Dialicels system is comparable to administering a continuous I.V. drip.

Decrease in number of doses contributes to greater loyalty and adherence to the treatment.

Increase in stability.

Decrease in AE’s vs. common drugs.

The Dialicels system does not modify intestinal peristalsis, gastrointestinal enzymes, pH, food, flora, biliary secretion and does not show adverse interactions with other drugs.

Disguises original drug flavor.

Dialicels. Is the registered trademark of medix for capsules that contain micro-spheres (pellets) that perform as microcells. These micro-spheres have a dialyzer membrane that allows a sustained-slow release of drugs.

THE DIALICELS SYSTEM THE DIALICELS SYSTEM

Nucleus

Medication

Dialyzing Material

Dialicels® Make-Up

Advantages of Dialicels®

Increasing the bioavailability of orally administered medications so as to be comparable with a continuous IV drip. The benefits of bioavailability of the Dialicels® system can be osbserved in the following areas:

1.- Digestive Apparatus

2.- Absorption

3.- Blood concentrations

4.- Tissues

5.- Medical Prescriptions

6.-Patient Comfort

Products Developed using the Dialicels® system

•  Indometacine •  Dextrometorfane •  Fenproporex •  Ferrous Fumarate •  Ketoprofene •  Amfepramone •  Tramadol •  D-Norseudoefedrine, Triyodotironine, Diazepam, Atropine and Aloine •  Lorazepam •  Mazindol •  Melatonine

Product Categories Product Categories

Major Rx Players into the industry

Source: INTE

70% 12%

5%

4%

5%

1% 1%

2%

At present medix has a commercial list of 45 products positioned mainly in this categories:

–  Gastroenterology –  Others ( General Medicine). We are also Developing new products for : -  Central Nervous system -  Metabolism

14%

4%

1%

8%

3%

4%

2%

0.05%

3%

1%

3%

3%

0.026%

52%

medix Portfolio by Segment

Source: PMM

GENERICS GENERICS

EVOLUTION OF GENERICS IN MEXICO

Generics in niches with good demand; average 2-3 producers as competition.

Outsourcing Agreement

• Health Mart

Health Mart Partnership Objectives

•  As a strategic partner for medix to manage the commercialization process (current and New products) in an effective, efficient and highly profitable manner.

•  To facilitate the medix strategic focus on processes that deliver competitive advantages within the Mexican Pharmaceutical Market.

Partnership Terms

•  Health Mart fee’s of medix net sales •  Medical samples sold to Health Mart. •  Cost of discounts and/or promotional activities charged

to medix •  Marketing plans authorized by medix •  medix entitled to field monitoring and marketing plan

implementations •  Monthly review of KPI´s

Strategic Partnership medix-Health

•  We have a sales force of 192 collaborators

Customer Relationship Management

Customer Relationship Management

CRM

www.medix.com.mx

The main objective of our loyalty program is to establish direct links of relationship with physicians to obtain valuable information; in this way, we may understand their potential as clients, directing and targeting to continue making our promotional efforts more profitable.

Call center

OUR WEB PAGE

EXPORTS EXPORTS

medix Distribution network in 10 Latin American countries.

Our Immediate future

•  Pharmaceutical Research Center.

*Under Development , Expected for 2008.

Our goal is the future!